中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共8条，第1-8条

帮助

条数/页：排序方式：
	Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文 OAI收割 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18 作者: Li, Ning; Zhu, Jianqing; Yin, Rutie; Wang, Jing; Pan, Lingya \| 收藏 \| 浏览/下载：37/0 \| 提交时间：2022/12/23
	Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者: Yin, Rutie; Li, Ning; Wu, Lingying; Wang, Jing; Zhu, Jianqing \| 收藏 \| 浏览/下载：30/0 \| 提交时间：2022/12/23
	Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文 OAI收割 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022 作者: Liu, Jihong; Yin, Rutie; Wu, Lingying; Zhu, Jianqing; Lou, Ge \| 收藏 \| 浏览/下载：64/0 \| 提交时间：2022/05/05 BRCA mutation China olaparib ovarian cancer PARP inhibitor
	Investigating Historical Baseflow Characteristics and Variations in the Upper Yellow River Basin, China 期刊论文 OAI收割 INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 卷号: 19, 期号: 15 作者: Zhao, Guizhang; Kong, Lingying; Li, Yunliang; Xu, Yuanzhi; Li, Zhiping \| 收藏 \| 浏览/下载：3/0 \| 提交时间：2023/12/19
	Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文 OAI收割 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者: Yang, Jiaxin; Wu, Xiaohua; Zhu, Jianqing; Song, Liang; Feng, Yanling \| 收藏 \| 浏览/下载：52/0 \| 提交时间：2021/11/01
	Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文 OAI收割 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者: Huang, Qidan; Wu, Xiaohua; Zhu, Jianqing; Wang, Danqing; Yang, Jiaxin \| 收藏 \| 浏览/下载：36/0 \| 提交时间：2021/11/01
	Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者: Wang, Jing; Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin \| 收藏 \| 浏览/下载：30/0 \| 提交时间：2022/01/10
	Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者: Wu, Lingying; Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin \| 收藏 \| 浏览/下载：37/0 \| 提交时间：2022/01/10